Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
00719 SHANDONG XINHUA
3.830
+0.140+3.79%
YOY
Do not show
Hide blank lines
(Q6)2022/06/30(Q3)2022/03/31(FY)2021/12/31(Q6)2021/06/30
Assets
Current assets
Inventory
22.58% 1.04B -- -- -8.61% 1.03B 7.12% 844.47M
Accounts receivable
4.79% 863.21M -- -- 73.35% 658.57M 36.76% 823.76M
Notes receivable
-- 27.91M -- -- -- 41.02M -- --
Insurance and other receivables-current assets
23.95% 182.72M -- -- 14.68% 187.84M -18.12% 147.42M
Cash and equivalents
17.07% 1.11B -- -- -12.98% 744.66M -14.86% 948.75M
Other current assets
-19.08% 28.69M -- -- -60.91% 44.59M -43.42% 35.46M
Total current assets
15.43% 3.29B -- -- 2.5% 2.75B 1.34% 2.85B
Non-current assets
Fixed assets
12.25% 3.4B -- -- 2.5% 3.2B 10.42% 3.03B
Investment property
-8.88% 43.64M -- -- -8.5% 45.77M -8.14% 47.89M
Construction in progress
-21.39% 446.68M -- -- 35.01% 562.96M 12.51% 568.19M
long-term investment
1.58% 59.32M -- -- -1.88% 56.71M -0.23% 58.39M
Intangible assets
5.88% 480.91M -- -- 3.83% 466.45M 10% 454.18M
Deferred tax assets
-24.78% 16.24M -- -- -35.5% 15.17M -30.71% 21.59M
Other illiquid assets
-66.28% 3.94M -- -- -10.6% 14.23M -- 11.67M
Special items of non-current assets
11.97% 16.18M -- -- 10.5% 18.19M 882.18% 14.45M
Total non-current assets
5.32% 4.66B -- -- 3.9% 4.58B 10.99% 4.42B
Total assets
9.28% 7.95B -- 7.67B 3.37% 7.33B 7% 7.27B
Liabilities
Current liabilities
Accounts payable
23.81% 653.71M -- -- 46.01% 661.32M 15.28% 528M
Notes payable
44.64% 546.07M -- -- 39.69% 405.07M 68.24% 377.55M
Tax payable
25.68% 40.53M -- -- 22.47% 28.25M 15.68% 32.25M
Other payables and accrued expenses
1.82% 576.44M -- -- 0.59% 498.1M 31.62% 566.11M
Short-term borrowing
11.48% 369.07M -- -- 34.44% 269.46M 43.95% 331.07M
Other current liabilities
129.21% 30.06M -- -- 39.34% 45.59M -- 13.11M
Special items of current liabilities
97.34% 973.58M -- -- -3% 493.69M -16.51% 493.35M
Total current liabilities
31.09% 3.29B -- -- 5.08% 2.5B 9.41% 2.51B
Net current assets
-99.68% 1.08M -- -- -17.58% 252.08M -34.28% 341.06M
Total assets less current liabilities
-2.2% 4.66B -- 7.67B 2.51% 4.83B 5.78% 4.76B
Non-current liabilities
Long-term bank loan
0.94% 371.43M -- -- -25.19% 346.2M -24.21% 367.97M
Long-term accounts payable
-- -- -- -- -1.78% 627.2M -3.09% 640.37M
Deferred tax liability
0.02% 84.87M -- -- -5.35% 65.61M 66.17% 84.86M
Deferred income-non-current liabilities
-12.37% 123.97M -- -- -8.66% 132.16M -5.53% 141.47M
Other non-current liabilities
0% 3.56M -- -- 0% 3.56M 0% 3.56M
Special items of non-current liabilities
151.34% 4.25M -- -- 142.74% 4.28M 267.43% 1.69M
Total non-current liabilities
-52.57% 588.08M -- -- -10.72% 1.18B -8.23% 1.24B
Total liabilities
3.41% 3.87B -- -- -0.56% 3.68B 2.86% 3.75B
Total assets less total liabilities
15.52% 4.07B -- 7.67B 7.66% 3.65B 11.78% 3.52B
Total equity and non-current liabilities
-2.2% 4.66B -- 3.85B 2.51% 4.83B 5.78% 4.76B
Equity
Share capital
6.74% 669.63M -- -- 0.89% 627.37M 0.89% 627.37M
Legal reserve
7.49% 325.19M -- -- 7.49% 325.19M 8.46% 302.54M
Capital reserve
41.87% 958.22M -- -- 5.12% 677.94M 6.18% 675.42M
Undistributed profit
13.88% 1.8B -- -- 15.69% 1.71B 17.52% 1.58B
Special items of shareholders' rights and interests
-15.03% 120.33M -- -- -27.56% 128.37M 1.59% 141.62M
Shareholders' Equity
16.4% 3.88B -- -- 7.57% 3.47B 10.14% 3.33B
Non-controlling interest
0.46% 194.9M -- -- 9.38% 183.2M 50.04% 194.02M
Total equity
15.52% 4.07B -- 3.85B 7.66% 3.65B 11.78% 3.52B
Total equity and total liabilities
9.28% 7.95B -- 3.85B 3.37% 7.33B 7% 7.27B
Currency Unit
CNYCNYCNYCNY
Accounting Standards
CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions
----Unqualified Opinion--
Auditor
----Shin Yong Zhonghe accounting firm--

Q6, Q9, and FY are cumulative quarterly reports: Q6 is the interim report; Q9 is third quarter report; FY is the annual report.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
Shandong Xinhua Pharmaceutical Co., Ltd. is a Chinese company mainly engaged in the development, manufacture and sales of chemical raw materials, preparations and pharmaceutical intermediates. The company's products mainly include analgin, caffeine, aminopyrine, aspirin, hydrocortisone, pipemidic acid, ibuprofen, levodopa, pipemidic acid tablets, compound licorice tablets and nimodipine tablets. The company's products are sold to domestic and overseas markets in China, including the Americas and Europe.
CEO: Tongqing He
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...